AeroSafe Global: Leading Temperature-Controlled Pharmaceutical Shipping Solutions
Rochester-Based Company Revolutionizes Cold Chain Logistics for Life-Saving Medications
AeroSafe Global, a Rochester, New York-based pharmaceutical shipping company, has transformed from a 15-year industry veteran into a global leader in temperature-controlled drug transport. The company’s innovative cold chain logistics solutions gained unprecedented recognition during the COVID-19 pandemic, attracting a $30 million investment from New York State.
Advanced Temperature-Controlled Shipping Technology
Operating from their Buffalo Road facility, AeroSafe Global manufactures state-of-the-art pharmaceutical shipping containers that ensure medication integrity throughout the supply chain. These reusable shipping boxes feature:
- Real-time GPS tracking and location monitoring
- Precise temperature control systems
- Chain of custody documentation
- 100-use lifecycle for sustainable shipping solutions
“We can tell exact location, real-time and temperature and even chain of custody if need be so we know when it arrives at your house,” explains CEO Jay McHarg.
COVID-19 Vaccine Distribution Success
AeroSafe Global played a critical role in COVID-19 vaccine distribution across the United States. The company’s temperature-sensitive medication transport solutions were essential for:
- Pfizer vaccine shipments requiring ultra-cold storage
- Merck pharmaceutical products distribution
- International vaccine delivery to Japan, US, and Europe
- State, county, pharmacy, and hospital distribution networks
“Almost every COVID-19 vaccine transported from the drug makers to states, counties, pharmacies and hospitals across the United States was sent in shipping containers developed and produced right here in Rochester,” highlighting the company’s market dominance.
Strategic Partnerships with Major Pharmacy Chains
The company expanded its reach through partnerships with leading pharmacy chains:
- CVS Health cold chain solutions
- Walgreens temperature-controlled delivery
- Long-term care facility pharmaceutical distribution
- Digital tracking integration for complete supply chain visibility
New York State Investment Recognition
New York State Comptroller Tom DiNapoli recognized AeroSafe Global’s exceptional growth, leading to a $30 million state pension fund investment. This investment reflects:
- Unprecedented business growth during COVID-19
- Strategic positioning in essential pharmaceutical services
- Strong market demand for specialized shipping solutions
- Proven track record in life-saving medication delivery
“The growth has been incredible and when you look at how many businesses suffered during COVID, some of which went out of business, this was a company because of the uniqueness of their product and their delivery service,” notes Comptroller DiNapoli.
Company Mission and Future Growth
CEO Jay McHarg emphasizes the company’s commitment to pharmaceutical supply chain excellence: “It’s the people in the company that do it and their passion for the cause. They go home at the end of the day and the containers they made are saving lives.”
AeroSafe Global continues expanding its temperature-controlled logistics capabilities, maintaining its position as an industry leader in pharmaceutical cold chain management and life-saving medication transport.